Skip to content

Live Events

Live Events

Live Events

Live Events

MEC Basic Full List View

By pinki@katapult.biz / February 16, 2025

MEC Basic

Events

Type of Media

Title

Speciality

Author / Speaker

Search Entries:

«
1
…
33
34
35
36
37
…
66
»

Management of Side Effects of Soome Common Targeted Therapies (ALK/BTK/IDH 1/2 Inbibitors

Management of Side Effects of Soome Common Targeted Therapies (ALK/BTK/IDH 1/2 Inbibitors

Paola Izquierdo, ARNP, BSN, FNP-BC

New Approaches for Follicular Lymphoma

New Approaches for Follicular Lymphoma

Nakhle S. Saba, MD

DLBCL & Hodgkin’s Disease: Novel Approaches

DLBCL & Hodgkin’s Disease: Novel Approaches

Eduardo Sotomayor, MD

T-Cell NHL: Novel Approaches & Challenges

T-Cell NHL: Novel Approaches & Challenges

Steven Rosen, MD

RET, MET & NTRK Mutations in NSCLC

RET, MET & NTRK Mutations in NSCLC

Mark Socinski, MD

ALK, ROS1 & BRAF Mutations in NSCLC

ALK, ROS1 & BRAF Mutations in NSCLC

Jonathan Riess, MD, MS

EGFR, K-RAS and ERBB2 Mutations in NSCLC

EGFR, K-RAS and ERBB2 Mutations in NSCLC

Edgardo S. Santos Castillero, MD, FACP

Immunotherapy in Advanced/Metastatic NSCLC and What After IO Failures?

Immunotherapy in Advanced/Metastatic NSCLC and What After IO Failures?

Luis E. Raez, MD

Novel Treatment Strategies for Stage III NSCLC Beyond PACIFIC

Novel Treatment Strategies for Stage III NSCLC Beyond PACIFIC

Howard (Jack) West, MD

Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC

Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC

Karen Kelly, MD

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Paul A. Bunn, MD, FASCO

Novel Platforms for Lung Cancer Screening Using Liquid Biopsy

Novel Platforms for Lung Cancer Screening Using Liquid Biopsy

Natasha B. Leighl, MD, MMSc, FRCPC, FASCO

Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy

Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy

Mark Pegram, MD

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs more?

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs more?

Mohammad Jahanzeb, MD, FACP, FASCO

Immunotherapy for Triple Negative Breast Cancer

Immunotherapy for Triple Negative Breast Cancer

Windy Dean-Colomb, MD, PhD

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

Joyce O’Shaughnessy, MD

Antibody Drug Conjugated for Breast Cancer: Current Therapy and New Directions

Antibody Drug Conjugated for Breast Cancer: Current Therapy and New Directions

Hope Rugo, MD, FASCO

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Sybil Richard Green, JD, MHA, BS Pharm

Initiatives to Improve Equity and Inclusion in Healthcare

Initiatives to Improve Equity and Inclusion in Healthcare

Kashyap Patel, MD, ABOIM

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Chanita Hughes-Halbert, PhD

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

Belisario Arango, MD

Immunotherapy, Targeted Therapy & And What After in Melanoma?

Immunotherapy, Targeted Therapy & And What After in Melanoma?

Sanjiv Agarwala, MD

Toxicities in Immunotherapy

Toxicities in Immunotherapy

Lisa Kottschade, APRN, MSN, CNP

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Thomas Herzog, MD

Immunotherapy in Kidney & Bladder Cancer

Immunotherapy in Kidney & Bladder Cancer

Primo N. Lara, Jr., MD

Immunotherapy in Head & Neck Cancer and What After IO Failure?

Immunotherapy in Head & Neck Cancer and What After IO Failure?

Robert Haddad, MD

Sarcomas: GIST, Osteosarcoma & Soft Tissue Sarcomas

Sarcomas: GIST, Osteosarcoma & Soft Tissue Sarcomas

Pasquale W. Benedetto, MD

Neuroendocrine Tumors (NET): Novel Advances in Therapy

Neuroendocrine Tumors (NET): Novel Advances in Therapy

Lowell Anthony, MD, MS, FACP

Cancer Screenings, Reducing Mortality

Cancer Screenings, Reducing Mortality

Adrienne Vazquez Guerra, MSN, ACNP-BC, AOCN

Removing Barriers and Myths in Geriatric Oncology

Removing Barriers and Myths in Geriatric Oncology

Tom Reske, MD, PhD, FACP, CMD, AGSF

Displaying 1,021 - 1,050 of 1,953

«
1
…
33
34
35
36
37
…
66
»

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.